Conformation-dependent hydrophobic photolabeling of the nicotinic receptor: Electrophysiology-coordinated photochemistry and mass spectrometry by Leite, John F. et al.
Conformation-dependent hydrophobic photolabeling
of the nicotinic receptor: Electrophysiology-
coordinated photochemistry and mass spectrometry
John F. Leite*†, Michael P. Blanton‡, Mona Shahgholi§, Dennis A. Dougherty§, and Henry A. Lester*
Divisions of *Biology and §Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125; and ‡Departments of Pharmacology
and Anesthesiology, Texas Tech University Health Sciences Center, Lubbock, TX 79430
Edited by William A. Catterall, University of Washington School of Medicine, Seattle, WA, and approved August 22, 2003 (received for review May 16, 2003)
We characterized the differential accessibility of the nicotinic acetyl-
choline receptor 1 subunit in the open, closed, and desensitized
states by using electrophysiology-coordinated photolabeling by sev-
eral lipophilic probes followed by mass spectrometric analysis. Volt-
age-clamped oocytes expressing receptors were preincubated with
one of the lipophilic probes and were continually exposed to acetyl-
choline; UV irradiation was applied during 500-ms pulses to  40 or
to 140 mV (which produced closed or 50% open receptors, re-
spectively). In the open state, there was specific probe incorporation
within the N-terminal domain at residues that align with the 8–9
loop of the acetylcholine-binding protein. In the closed state, probe
incorporation was identified at several sites of the N-terminal domain
within the conserved cysteine loop (residues 128–142), the cytoplas-
mic loop (M3–M4), and M4. The labeling pattern in the M4 region is
consistent with previous results, further defining the lipid-exposed
face of this transmembrane -helix. These results show regions
within the N-terminal domain that are involved in gating-dependent
conformational shifts, confirm that the cysteine loop resides at or
near the protein-membrane interface, and show that segments of the
M3–M4 loop are near to the lipid bilayer.
The nicotinic acetylcholine receptor (nAChR) is a well charac-terized ligand-gated ion channel in a superfamily that also
includes the glycine, -amino-butyric acid type A, and serotonin
5HT3 receptors (1). Transitions among the resting (nonconduct-
ing), open (conducting), and desensitized (nonconducting) states
are crucial for proper neuronal function (2). During agonist-
activated channel opening, the receptor undergoes a series of
molecular motions that propagate from the ligand-binding domain
to the pore domain (for review see ref. 3). Given the probable
complexity of these molecular motions as well as their time-
dependence, it is unlikely that they will be resolved by any single
methodological approach; instead, this problem requires a combi-
nation of approaches that provide both high-resolution static struc-
tural information as well as lower-resolution time- and state-
dependent information.
In recent years there has been good progress toward understand-
ing of the overall structure of the nAChR (4, 5), including high-
resolution information regarding the structural changes that occur
during receptor state transitions. We now have some understanding
of the motions that occur during gating within the channel-lining
domain (M2), and to some extent within the M1 domain (6–8).
However, less is known of the transitions that occur in domains
distal to the pore. Mutations at the extracellular M2–M3 loop cause
congenital myasthenic syndrome by disrupting the link between
ligand binding and channel activation, as revealed by effects on
gating kinetics (9). The conserved cysteine loop is one structural
element required for coupling ligand-binding to gating in nAChR
and -amino-butyric acid receptor type A (10, 11). Additional
recent hypotheses about conformational changes within the N-
terminal region are based on the structure of the acetylcholine-
binding protein (AChBP) (4, 12). Site-directed mutagenesis of
nAChR, analyzed by linear free-energy relations, suggest that the
transition from the resting to the open state involves a series of
conformational shifts, originating at the ligand binding domain and
propagating to the channel domain (13).
Hydrophobic photoreactive probes have been useful in the
topological analysis of nAChR conformational states (14, 15).
These probes (i) allow identification of protein segments that are in
contact with the lipid bilayer, and (ii) yield inferences about
secondary structure from the periodicity of photolabeled residues
in a given lipid-exposed domain. Data for the hydrophobic photo-
reactive agent 3-trifluoromethyl-3-m-iodophenyl diazirine (TID)
suggested a periodicity in M4 and M3 consistent with an -helical
fold. Fortuitously, TID is also a noncompetitive antagonist of the
nAChR channel (16–18). Agonist-dependent changes in TID pho-
toincorporation in the channel-lining M2 segments were observed
with the nAChR, revealing the potential of using TID as a tool for
studying gating-dependent conformational transitions (19). Benzo-
phenone (BP), another hydrophobic photoreactive probe, has been
used to map ligand binding sites (for review see ref. 20). This study
employs the acetate and trimethyl-acetate (21) derivatives of TID
(TIDBAc and TIDBTMAc, respectively) as well as BP derivatives
(Fig. 1A).
We sought to use these probes to photolabel the open, resting,
and desensitized states of the nAChR, potentially revealing state-
dependent structural transitions. The sensitivity of MS encouraged
us to photolabel the relatively small quantities of nAChRs present
in membranes during voltage-clamp experiments. We devised a
protocol that (i) switched from mostly closed to mostly open states
within a few milliseconds, and (ii) photolabeled channels during a
time (500 ms) too brief for appreciable changes in desensitization.
We exploited the modest voltage dependence of agonist-induced
nAChR channel activation: under appropriate conditions, the
fraction of open channels increases at more negative potentials, at
a rate of e-fold per 66–85 mV (22–26). In a two-electrode voltage
clamping apparatus that includes a shutter-controlled UV light
source (Fig. 2), irradiation was applied during either depolarizing
or hyperpolarizing pulses (in the presence of ACh), thus, photola-
beling channels that were mostly in the resting or open state,
respectively.
Subsequently, the labeled nAChR were isolated, enzymatically
digested, and analyzed by ‘‘on-line’’ capillary liquid chromatogra-
phy (LC) with electrospray (ESI) (27) tandem mass spectrometry
(MSMS) (28) using an ion trap mass spectrometer to determine
the sites of probe incorporation. In this approach, masses of
photolabeled nAChR proteolytic peptides are determined by the
ion trap mass spectrometer as each peptide elutes from the LC
column. Potential sites of probe incorporation are subsequently
determined by collision-induced dissociation (CID) (28) and MS
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MS, which can provide partial to complete amino acid sequence
information. These mass spectrometric and analytic procedures are
described in ref. 29.
Mass spectra of unmodified nAChR were compared with those
of modified nAChR to identify those ions that had photoincorpo-
rated one or more probe moieties. MSMS analysis of these species
provided additional evidence of probe photoincorporation and
often identified the specific residue where labeling had occurred.
Finally, we compared data from the open state with those from the
resting state and identified those residues that were uniquely
labeled in the open state, and we used analogous approaches to
identify residues specifically labeled in desensitized state(s). State-
dependent changes were indeed identified from differences in the
photolabeling patterns between the open, resting, and desensitized
states. We use the acronym ECP-MS for electrophysiology-
coordinated photolabeling with subsequent MS analysis.
Materials and Methods
nAChR Expression. nAChR 1, , , and  subunits (mouse muscle)
were subcloned into pCDNA. A polyhistidine tag (located at the C
terminus) and a hemagglutinin epitope in the M3–M4 cytoplasmic
loop (after D347) were engineered into the nAChR 1 subunit (the
numbering of amino acid residues after D347 is thus 8 residues
greater than in the wild-type protein). Dose–response studies for
this construct (mouse 1 hemagglutinin:HIS, , , ) indicated that
the EC50 (25.5M) and Hill coefficient (1.26) were near previously
reported values for the wild-type nAChR (6). Xenopus laevis
(Xenopus One, Dexter, MI) oocytes were surgically removed and
injected with 1 ng of total cRNA as described (6). Average currents
recorded from oocytes expressing nAChR 24–48 h after injection
ranged from 2 to 10 A with 50 M ACh.
Two-Electrode Voltage Clamping and UV Irradiation. Oocytes ex-
pressing nAChR were assayed by whole-cell recording using a
two-electrode voltage clamping apparatus that includes a shutter-
controlled UV light source beneath the oocyte bath (Fig. 2) (30, 31).
The oocyte chamber was continuously perfused with Ca2 free
ND-96 at 120 chamber volumesmin for 1 min before analysis. The
very high expression levels probably led to ionic accumulation and
series resistance artifacts that cause underestimates of responses at
140 mV. Recordings were measured with a GeneClamp 500
(Axon Instruments) interfaced with a computer by DIGIDATA 1200
(Axon Instruments), recording and analysis performed by PCLAMP
software (Axon Instruments). Oocytes were impaled with 3M
KCl-filled electrodes (0.7–1.5 M resistance).
Photoincorporation of Hydrophobic Photoreactive Probes. A 10 mM
stock of BP (Aldrich) was prepared in 95% ethanol and stored at
4°C in a brown-glass vial. A 15 mM stock TIDBAc and a 1.5 mM
stock of TIDBTMAc (21) were stored at 20°C. Cholesteryl
benzoylphenyl propionate (CBPP) was synthesized by the esterifi-
cation of ketoprofen (Sigma) and cholesterol (Avanti Polar Lipids)
by adapting the protocol outlined in (32). Presence of the ester was
confirmed by thin layer chromatography and NMR spectroscopy.
Oocytes expressing nAChR were initially preincubated (30 min)
with TIDBAc, TIDBTMAc (15 M), and BP (10 M) in ND-96.
Oocytes were transferred from the labeling solution to ND-96
medium before recording. To further remove aqueous probe,
oocytes were washed on the rig with Ca2-free ND-96 for 1 min. A
1 mM solution of CBPP was mixed with 1 mM methyl--
cyclodextrin (MCD) in ND-96. Oocytes were incubated for 40 min
with the MCD:CBPP solution in the dark.
The holding potential was 80 mV; each sweep consisted of
500-ms pulses at40 mV (500 ms), then at140 mV (Fig. 2 Upper).
Fig. 1. Hydrophobic photoreactive probes and nAChR topology. (A) The struc-
tures of BP, TIDBTMAc, TIDBAc, and CBPP are illustrated. Photolabeled peptides
show a mass shift of 182.1 Da, 398.1 Da, 356.1 Da, and 622.9 Da, respectively. (B)
The commonly accepted topological model for nAChR1. This includes the cys-
teine loop (residues 128–142), a four-transmembrane domain (M1–M4, residues
210–437), and a cytoplasmic loop between M3 and M4 (residues 299–417). The
pore-lining domain, M2 (residues 243–261), is highlighted in black.
Fig. 2. Electrophysiology-coordinated photolabeling. The two-electrode volt-
age clamping apparatus is equipped with a UV light source. Filtered, shutter-
controlled UV light (340 nm) irradiates the oocyte via the liquid light guide in
achamberequippedwithacoverslipbottomwindow.Thetraceonthe left shows
the inward current induced by 10M ACh at a holding potential of80 mV. The
bars labeled by the letters A or B identify periods when the voltage-jump-
irradiation episodes occurred, corresponding to A and B at right. The top right
tracedescribesthevoltage-jumpprotocol.Eachsweepconsistedoftwosuccessive
500-ms epochs: the membrane potential was jumped first to 40 mV, then to
140 mV. The experiments in traces A and B were conducted in the absence of
ACh and the steady presence of 10 M ACh, respectively. The ACh-induced
currents are shown by subtracted traces in trace C. These sweeps were repeated
five times at 1.2-s intervals, and the lamp shutter was opened either during each
40 mV epoch or during each 140 mV epoch. These experiments provided a
series of oocytes described as ‘‘40 mV, no agonist,’’ ‘‘140 mV, no agonist,’’
‘‘40 mV, ACh,’’ and ‘‘140 mV, ACh.’’ Only the oocytes described as ‘‘140 mV,
ACh’’ are expected to have appreciable number of receptors photolabeled in the
open state.
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The shutter was programmed to open either during each entire
pulse40 mV or during each entire pulse to140 mV (Fig. 2). The
shutter was opened during five successive sweeps. Photolabeling in
the closed state was performed either while the oocyte was being
perfused with Ca2-free ND-96, in the absence of agonist (Fig. 2,
trace A) at 40 mV or at 140 mV, or during 40 mV pulses in
the presence of 10 M ACh (Fig. 2, trace B,40 mV). These three
conditions gave equivalent mass spectra and the data were pooled.
Photolabeling nAChR in the open state was performed during
140-mV pulses in the presence of 10 M ACh. To photolabel
nAChR in the desensitized state, oocytes were preincubated in
Ca2-free ND-96 including 500 M Ach for 5 min, then exposed to
UV irradiation for 5 s.
Extraction and Purification of nAChR 1 Subunit. Photolabeled oo-
cytes (15–20 oocytes per sample) were stored at 80°C imme-
diately after the experiment. Oocytes were thawed on ice in a 1.5-ml
tube, and transferred to lysis solution [50 mM ammonium bicar-
bonate, pH 7.8antiprotease (Complete, Boehringer Manheim)].
Oocytes were lysed with a 1-ml pipetter; however, yolk sacs were left
intact and allowed to settle to the bottom of the tube. Total
membranes were solubilized [lysis buffer, 0.1% Triton X-100
(Sigma)] and applied to 400 l Ni2 NTA agarose beads (Qiagen,
Valencia, CA). After elution with solubilization buffer plus 500 mM
imidazole (Aldrich), sample was dried down and resuspended in
SDSPAGE loading buffer [50 mM Tris, pH 8.05% 2-mercapto-
ethanol1 M urea5% glycerolbromophenol blue (Sigma)]. Sam-
ple was loaded onto a SDS10% PAGE gel (Bio-Rad), followed by
electrophoresis for 2 h at 70 V. The nAChR 1 subunit was
identified by Coomassie blue staining of the 10% gel, the gel band
was excised, and the protein was extracted as described (56). The1
subunit was digested with 1 g of Endo-Glu-C protease (Pierce).
Samples were dried and stored at 80°C until analyzed.
MS. Proteolyzed nAChR peptides were separated and analyzed by
LC-MS (Finnigan model LCQ ion trap equipped with a custom
nanospray interface and Surveyor LC system). Flows were adjusted
for capillary chromatography by using a tee to split the flow from
the HPLC unit. Uncoated fused silica PicoFrit capillary columns
(inner diameter, 75 m) (Scientific Instrument Services) were
packed with 10 m of C18 or C4 reverse-phase beads (Michrom)
by using a helium bomb. Columns were packed to 5-cm length
routinely yielding a backpressure of1,500 psi at 500–1,000 nlmin
of 10% acetonitrile, 100 mM acetic acid. Linear, dual solvent
gradients were used 90% Solvent A (100 mM acetic acid)10%
Solvent B (99% acetonitrile100 mM acetic acid) to 30% Solvent
A70% Solvent B. Spectra were acquired for 40 min; spray voltage,
2 kV; capillary temperature, 180°C; capillary voltage, 44.5 V; tube
lens, 4 V.
Results and Discussion
Oocytes expressing nAChR and incubated with a hydrophobic
photoreactive probe were irradiated with UV light under con-
ditions designed to provide the largest possible voltage-
dependent change in open probability (Fig. 2). In 10 M ACh,
the expected open probability at 40 mV is 3%; and the
hyperpolarizing jump of 180 mV increased the ACh-induced
conductance by nearly the expected ratio of 15.3-fold (shown by
subtracted traces in Fig. 2, trace C). Although we are confident
that the ‘‘closed state’’ receptors were a pure population, the
modest voltage dependence of nAChR activation prevented us
from devising a protocol that shifted nearly 100% of the channels
to an open state. Therefore the ‘‘140 mV, ACh’’ oocytes have
a mixed population of channels, open and closed. To identify
residues that were photolabeled uniquely in the open state, we
emphasize residues that were labeled only in the ‘‘140 mV, 10
M ACh’’ samples (Table 1 presents this analysis).
Our procedures were designed to yield a nearly pure population
of nAChR in each of three conditions: no ACh,40 mV; no ACh,
140 mV; and 10 M ACh, 40 mV. These experimental condi-
tions did yield equivalent photolabeling results, and thus the data
were pooled in Table 1.
Photolabeled Residues Identified Within the N-Terminal Domain.
ECP-MS analysis of the nAChR 1 proteolytic fragments labeled
in the open state indicated that several residues in the N-terminal
domain were indeed photolabeled. The photolabeled peptides were
detected at mass to charge ratios (mz) 572.2, 721.6, and 437.5
Table 1. nAChR 1 photolabeled residues identified by MSMS
mz (MeMo)z Fragment Residue(s) z Probe
Open state
721.6 0.5 153–163 -GSVVAINPESD ND 2 TIDBAc
572.2 1.2 162–172 -SDQPDLSNFME- L167 3 TIDBTMAc, K
437.5 0.2 173–180 -SGEWVIKE- ND 3 BP
784.4 0.2 417–441 -HILLGVFMLVCLIGTLAVFAGRLIE- F435 4 TIDBTMAc, K
1,138.8 1.0 417–441 -HILLGVFMLVCLIGTLAVFAGRLIE- T431 3 TIDBAc
Closed state
538.4 0.7 130–139 -IIVTHFPFDE- H134 3 TIDBTMAc
424.5 0.4 130–138 -IIVTHFPFD- H134 3 BP
525.5 0.3 130–139 -IIVTHFPFDE- H134 3 TIDBAc
570.4 0.7 130–138 -IIVTHFPFD- H134 3 CBPP
872.2 0.6 181–200 -ARGWKHWVFYSCCPTTPYLD- T196 3 BP
726.8 0.7 339–344 -KRIFTE- K339 2 CBPP, K
995.5 1.0 417–441 -HILLGVFMLVCLIGTLAVFAGRLIE ND 4 CBPP, K
871.2 0.9 417–441 -HILLGVFMLVCLIGTLAVFAGRLIE- C427 4 TIDBAc, NH4, C
960.2 0.9 417–441 -HILLGVFMLVCLIGTLAVFAGRLIE- F435 4 TIDBAc, NH4, C
955.4 0.1 417–441 -HILLGVFMLVCLIGTLAVFAGRLIE- F435, R438, E441 4 TIDBAc, K, O
Desensitized state
437.3 0.4 173–180 -SGEWVIKE- W176, V177 3 BP
453.1 0.9 336–344 -KQEKRIFTE- R340 3 BP
1,161.9 0.1 355–380 -YAISDISGKPGPPPMGFHSPLIKHPE- S373, P379 3 TIDBAc
Modified residues are grouped according to the macroscopic conductance state (open, closed, desensitized). Listed are the mass to charge ratios observed
(mz), the mass difference between the expected mass and the observed mass divided by the charge-state (z), [(Me  Mo)z], the sequence of the modified
proteolytic fragment (modified residues in bold, underlined type; residues in italic and underlined type indicate that a modification resides within one of those
residues), and the probe used in the experiment. Salt adducts, such as potassium (K) or ammonium (NH4
), that contributed to the mass of the mass-ion are
identified. Carboxyamidomethyl moieties (C) or oxidations (O) at cysteine residues are also indicated. ND, not determined.
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(Table 1). Fig. 5, which is published as supporting information on
the PNAS web site, www.pnas.org, shows a typical tandem mass
spectrum of one of these photolabeled peptides, in this case, the ion
with mz 721.6 ([M  2H]2), which corresponds to G153–D163
plus one TIDBAc modification. The photolabeled y ion series
detected suggests that either y1 or y2 is the site of TIDBAc
incorporation. The y3 ion, because of the presence of proline, is the
most abundant fragment ion in the mass spectrum (see ref. 33 for
MSMS nomenclature). Other prominent ions in this mass spec-
trum are mz 446.4 and 359.2, which are attributed to unlabeled y4
and protonated TIDBAc. It appears that y4 loses the TIDBAc label
during collision-induced dissociation. Examination of this MSMS
mass spectrum narrows the site of TIDBAc incorporation to the
carboxy end of the peptide, residues S162 or D163. Similarly,
MSMS analysis of photolabeled peptide of mz 437.5 narrowed
the site of probe (BP) incorporation to S173G174 and K179E180.
For the photolabeled peptide with mz 572.2, MSMS analysis
indicated that L167 was uniquely labeled with TIDBTMAc. Thus,
unique nAChR1 residues were found photolabeled in the open
state between residues S162 and E180.
Analysis of nAChR 1 photolabeled in the resting state also
identified labeled residues located in the N-terminal domain. In this
case, H134 was photolabeled with TIDBTMAc (Fig. 6, which is
published as supporting information on the PNAS web site) as well
as with TIDBAc and BP (Table 1). Interestingly, this residue is
located within the highly conserved cysteine loop (see Fig. 1B),
found within the soluble N-terminal domain and thus was not
expected to gain access to the membrane interior. To confirm that
labeling of H134 was occurring at the protein-membrane interface,
we synthesized CBPP (Fig. 1A), and used it to photolabel nAChR
1. Previous studies have mapped the cholesterol-binding site of
nAChR within the transmembrane domain (34, 35), specifically
within M1 and M4 (36). Thus, we expected CBPP to partition into
the annulus of phospholipid and native cholesterol around the
nAChR. As anticipated, photolabeling of M4 was observed (Table
1, discussed further below) suggesting that CBPP localizes similarly
to cholesterol and cholesterol analogs. CBPP-photolabeled H134
was detected in the proteolytic fragment I130-D138 at mz 570.4,
[M3H]3. MSMS analysis of this peptide confirmed that H134
was photolabeled by CBPP (Table 1). Another residue photola-
beled in the resting state was T196. This residue was found in the
proteolytic fragment -ARGWKHWVFYSCCPTTPYLD-, which
was detected at mz 872.2 as a singly BP-photolabeled peptide
(Table 1). However, photolabeling at this site was never observed
by using the larger probes (i.e., TID derivatives or CBPP). We
hypothesize that BP may have partitioned into a hydrophobic
pocket that remains inaccessible to other probes.
Photolabeling of nAChR 1 residues located in the N-terminal
domain was also observed in the desensitized state. Specifically,
residues W176 and V177 (mz 437.3) were modified by BP (Table
1). These residues lie in close proximity to residues identified as
photolabeled by BP in the open state, S173G174 and K179E180
(see above). Although photolabeling at W176 and V177 is uniquely
observed in the desensitized state, we cannot assess whether this
new photolabeling pattern arises (i) from a conformational shift
occurring in the region within residues 173–180, or (ii) from changes
in structure(s) surrounding 173–180.
The nAChR N-terminal domain shares key residues with AChBP
of Lymnaea stagnalis (37), whose crystal structure (12) may thus
serve as a high-resolution model for the N-terminal domain of the
nAChR. We have projected our photolabeling data onto the
AChBP structure (Fig. 3): highlighted AChBP residues align with
photolabeled nAChR 1residues. In the open state (Fig. 3A),
modifications occurred within the region between residues S162
and E180. This region aligns with the AChBP 8–9 loop (12).
Thus, our results suggest that this region of the nAChR 1
N-terminal domain undergo conformational changes during the
transition from the resting state to the open state. This finding is
consistent with a recent report that compares the AChBP structure
with cryoelectron microscopy imaging of Torpedo nAChR in the
resting and open state, suggesting that the  subunit outer sheets
(which include8–9) rotate slightly as well as tilt during the resting
to open state transition (4). Also, our results are consistent with
fluorescence studies that suggest that a monoclonal antibody di-
rected at the high-affinity agonist binding site can induce the
movement of the low-affinity site toward the membrane (38) as well
as studies of -amino-butyric acid receptor type A that suggest the
8–9 loop changes its solvent exposure during channel gating (39).
Fig. 3B illustrates a single subunit of AChBP with the side chain
of D129 highlighted (which aligns with nAChR 1 H134). This
residue lies at the very bottom of the structure and, in the
N-terminal domain, would lie close to the membrane surface.
Furthermore, the cysteine loop in nAChR subunits contains more
hydrophobic residues than in AChBP (12). Therefore, we conclude
that this conserved structure makes contact with the membrane
surface in the resting state, and gains access to hydrophobic
photoreactive probes.
Fig. 3C highlights AChBP residues F171 and E172, which align
with nAChR 1 residues W176 and V177 (12). These residues
reside at the bottom of the AChBP structure. Correspondingly, we
conclude that nAChR 1 W176 and V177 move close to the
membrane surface in the desensitized state.
We have identified photolabeling in the N-terminal domain in
the open, resting, and desensitized states. For the most part, we
believe that this differential state-dependent labeling shows resi-
dues that approach the membrane. However, it is possible that
residues are photolabeled when they contact a hydrophobic pocket
(either within the N-terminal domain or at the transmembrane
domain) and that a photoreactive probe may partition to this region,
rather than make contact with the membrane surface. Indeed, this
appears likely for the specific case of T196, photolabeled in the
resting state uniquely by the compact BP molecule, but not detect-
ably by TID or CBPP. The reactivity of different probes varies
among amino acid side chains (40), so that in the present study some
residues may escape labeling primarily of their low reactivity. We
did not study possible labeling at the 8–9 loop in the open state
by CBPP because CBPP may alter nAChR function in the open
state (41, 42).
Fig. 3. AChBP residues homologous to nAChR1 photolabeled residues high-
lighted within the AChBP monomer structure. (A) AChBP residues photolabeled
in the open state. AChBP residues T156, N158, S162, Y168, S169, L174, and D175
align with nAChR1 residues S162, D163, L167, S173, G174, K179, and E180,
respectively. In the open state, photolabeling is present at L167 (red), residues
S162 or D163 (purple), S173 or G174 (yellow), and K179 or E180 (green). (B) The
AChBP D129 side chain (red), which aligns with the nAChR1 H134, photolabeled
in the closed state. (C) AChBP residues F171 and K172 which correspond to
nAChR1 residues W176 and V177, respectively. These residues (red) were iden-
tified as photolabeled in the desensitized state.
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Photolabeled Residues Identified Within the M3–M4 Loop. K339 (mz
726.8) is an example of a residue identified as photolabeled by
CBPP under both depolarizing and hyperpolarizing conditions
(Table 1). Topology models place this residue in an intracellular
loop (Fig. 1B) (3). As noted above, it is not possible to shift the
entire nAChR population to the open state during the hyperpo-
larizing pulse. Thus, one expects to observe a residue photolabeled
under both experimental conditions even if the residue is accessible
to photoprobes in only the resting state; however, our data do not
indicate whether this labeling occurred uniquely in the open state
conformation.
In desensitized nAChRs, unique photolabeled residues were
identified in the M3–M4 loop. For example, photolabeling by BP
was detected at residue R340 (mz 453.1), which is immediately
adjacent to the K339 residue that was photolabeled by CBPP in the
resting state (mz 726.8). Although photolabeling of this residue is
unique to the desensitized state, we cannot assess whether this shift
in the labeling profile is significant, given the close proximity of the
two modified residues. Furthermore, both K339 and R340 are
located in close proximity to the engineered hemagglutinin epitope
(residues 348–355), which may perturb the native structure within
this region in a fashion that is not detectable by the dose-response
analysis. Residues S373 and P379 within the1 M3–M4 cytoplasmic
loop (mz 1161.9) were also uniquely photolabeled in the desen-
sitized state. Photolabeled residues identified by the present study
suggest that segments of the M3–M4 loop may come in contact with
the membrane surface and may undergo conformational shifts
during the transition from the resting state to the desensitized state.
These results are consistent with limited proteolysis studies of the
glycine receptor that suggest regions of the M3–M4 loop are
peripherally associated with the membrane surface via either
electrostatic interactions with phospholipids head groups or residue
side chains from transmembrane domains (43). These results are
also consistent with imaging studies (44) and mutagenesis studies
(45), suggesting that the M3–M4 loop, in association with the pore,
is part of the ion conduction pathway.
Photolabeled Residues Identified Within M4. Previous studies reveal
that TID photoincorporates into each of the four membrane
spanning segments (Fig. 1B); labeling of the M1, M3, and M4
segments is consistent with direct exposure to the lipid bilayer
(reviewed in ref. 18). In the present study, we were able to detect
several residues within the nAChR 1 M4 segment that were
photolabeled with TID analogs (Table 1) in the resting state.
Specifically, nAChR 1 C427 (Fig. 7, which is published as sup-
porting information on the PNAS web site), F435, R438, and E441
were identified by MSMS analysis as photolabeled by a TIDBAc
moiety (Table 1).
In the open state, we identified T431 as photolabeled by
TIDBTMAc, in addition to TID-modified residues that were iden-
tified in the resting state. Although T431 is a uniquely photolabeled
residue in the open state, this residue lies on the same face of the
-helical projection of M4 (Fig. 4) as the other photolabeled
residues from the resting state. Thus, we cannot assess whether M4
undergoes any conformational shift during the transition from the
resting state to the open state by using the methodology presented
in this report.
The results shown in Fig. 4 illustrate that M4 photolabeled
residues identified by this study reside on the same helical face as
residues identified in previously published reports. Thus the present
results further define the lipid-exposed face of the M4 transmem-
brane -helix (46, 47).
Desensitization Does Not Distort the Identification of Residues La-
beled in the Open State. Desensitization is a complication. At
nicotinic receptors, desensitization is a shorthand word for a
complex and incompletely described set of agonist-induced transi-
tions to closed states. We assessed a slower phase of desensitization
by noting the currents induced by 10 M ACh at the 80 mV
holding potential during the photolabeling experiments (for in-
stance, Fig. 2 Left). The data showed that current declined by no
more than 1% by the end of the 6-s period that comprised the set
of voltage-clamp pulses. However, an additional possible source of
desensitized receptors is fast-onset desensitization, which occurs at
time constants on the order of 100–300 ms at mouse muscle
nicotinic receptors at the ACh concentrations we have used (48). As
usual in nAChR experiments, fast-onset desensitization might
actually occur during the solution change (500 ms). Both exper-
imental conditions ‘‘140 mV, ACh’’ and ‘‘40 mV, ACh’’ involve
exposure to the same agonist concentration for the same length of
time, and our procedure eliminated photolabeled residues common
to both experimental conditions. Importantly, we found no time-
dependent changes in ACh-induced current during the sojourns at
40 mV or at 140 mV (Fig. 2C). Therefore, fast-onset desensi-
tization may not be voltage dependent; but in any case, we conclude
that desensitization did not change between the40 mV and140
mV pulses. Therefore, the additional residues labeled in ‘‘140 mV,
ACh’’ oocytes cannot be distorted by fast-onset desensitization.
MS for Analyzing Ion Channel Conformational States. MS provides a
powerful and sensitive approach for analyzing chemically modified
residues in membrane proteins (49, 50). ECP extends this technique
for analyzing short-lived conformational states. The present ap-
proach does not require the use of site-directed mutants, and so the
potential structural perturbations induced by amino acid substitu-
tion are avoided. Furthermore, the present procedure does not rely
on a change in electrophysiological function to determine whether
reaction with a specific site has occurred. Thus, we are able to
analyze regions that might be functionally ‘‘silent’’ upon reaction
with a chemical reagent. Presently, there are limitations to the
technique: we were unable to detect the M1–M3 transmembrane
segments. We hypothesize that the hydrophobic and aggregative
nature of this region not only prevents efficient enzymatic prote-
olysis within this region, but possibly limits efficient ionization of
proteolytic fragments during MS analysis. However, the nAChR 1
M4 segment was detected and indeed, photolabeled residues were
identified by MSMS analysis (Table 1). Optimized solubilization,
proteolysis, and analysis techniques may allow detection of other
transmembrane segments.
Table 1 lists mass accuracies of the detected photolabeled
peptides. Some photolabeled peptides deviated markedly from
Fig. 4. Helical projection of nAChR1 M4 residues. Residues accessible to TID
analogs identified in the closed and open states are shown in red circles with bold
type. For further comparison, shown in green circles with underlined type are the
residues in the mouse muscle 1 AChR subunit that align with those in Torpedo
nAChR -subunit previously photolabeled by TID (46, 47, 55). C427 and T431
(shown in bold underlined type with redgreen circles) were identified by TID
incorporation both in previous studies and in the present study.
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expected masses. These deviations cannot be explained by ion
statistics, inability to effectively isolate the monoisotopic fragments,
fluctuation in radio frequency isolation of an ion, or mass shift
stemming from dissociative collisions between analyte ions and
buffer gas (51–53). Instead, we have determined, by analyzing
synthetic BP-photolabeled peptides, that the BP moiety underwent
a phenyl rearrangement and ketone formation, losing two hydrogen
atoms and producing species that were 2 Da lower in mass than
predicted (54). The data in Table 1 have not been adjusted to
account for effects of probe chemistry; however, these effects do
not alter the identity of the photolabeled residues.
In mass spectrometric studies of membrane proteins, as in
studies on other proteins, the extent of labeling can be measured
by comparing modified and unmodified peaks (50). During the
LC-MS analyses, unmodified proteolytic fragments often coe-
luted with or just before the analogous modified proteolytic
fragments. We therefore estimated labeling efficiency for a
specific peptide by calculating the ratio (peak areaphotolabeled
peptide)(peak areaphotolabeled peptide  peak areaunlabeled peptide).
These estimates assume that the photolabeled peptides show the
same ionization efficiency as the analogous unlabeled peptides,
and that the photolabel is not affecting the efficiency of pro-
teolytic cleavages at neighboring sites. Should photolabeling
interfere with proteolytic cleavage at neighboring residues or
affect the ionization of the proteolytic fragment, it is likely to
decrease the observed abundance of the photolabeled peptides
and therefore underestimate the actual photolabeling efficiency.
In this fashion, we estimate that labeling efficiency for the
I130-E139 region is 65% for TIDBAc and 47% for CBPP
labeling within I130-D138. In a separate study, we photolabeled
a synthetic peptide corresponding to nAChR 1 residues 130–
139 with BP in vitro and observed 10% labeling yields. Yields
from the present study are markedly higher than those reported
for TID labeling in Torpedo membranes (1%; ref. 17). The
reason for this difference may be the high receptor density of
Torpedo electroplaque membranes, which might interfere with
probe access to the receptor. We identified several M4 proteo-
lytic fragments that included more than one photoincorporation,
fully consistent with the high probability that we determined for
individual photoincorporations. These estimates, combined with
reproducibility of labeling sites, indicate that a significant and
representative population of receptors is being photolabeled.
Summary. We used electrophysiology-coordinated hydrophobic
photochemical labeling of the nAChR coupled to MS analysis to
identify residues in the 1 subunit that are uniquely photolabeled
in each of three functional states. Interestingly, we have detected
photolabeling of  H134 in the conserved cysteine loop in the
resting state. Also, we have identified several residues photolabeled
in the open state, located in a region that corresponds to the AChBP
8–9 loop. These results suggest that, during the transition from
the resting state to the open state, the 8–9 loop structure moves
from a hydrophilic environment to a hydrophobic environment, and
possibly makes contact with the membrane surface. Furthermore,
several photolabeled residues within the M3–M4 loop have been
identified in the resting state and desensitized state. These results
suggest that regions of the M3–M4 loop come in contact with the
membrane surface and also may shift conformation during the
transition from the resting state to the desensitized state.
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